Life Sciences staff make Converge 2021 Semi-finals
Dr Helge Dorfmueller and Dr David Martin from the School have been announced as semi-finalists of Converge 2021.
Dr Dorfmueller has created RhaPSeda, a platform that could prove decisive in the battle against the a contagious bacteria StrepA that kills 500,000 people annually, mainly from low-income countries. Despite a 100-year hunt for a vaccine, none currently exists with the pathogen showing increasing signs of antibiotic resistance. RhapSeda’s patented technology significantly reduces manufacturing costs, taking us a step closer to a worldwide solution to this global killer.